Trial Profile
A Randomised, Double-Blind, Placebo-Controlled, 2-Period Cross-Over Study in Healthy Male Volunteers, to Investigate Retinal Function Following a Single 800mg Oral Dose of AZD9056
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Jul 2015
Price :
$35
*
At a glance
- Drugs AZD 9056 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacodynamics
- 21 Jul 2008 New trial record.